Rixin Liang

973 total citations
48 papers, 795 citations indexed

About

Rixin Liang is a scholar working on Complementary and alternative medicine, Molecular Biology and Plant Science. According to data from OpenAlex, Rixin Liang has authored 48 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Complementary and alternative medicine, 15 papers in Molecular Biology and 11 papers in Plant Science. Recurrent topics in Rixin Liang's work include Traditional Chinese Medicine Analysis (19 papers), Neurological Disease Mechanisms and Treatments (7 papers) and Phytochemistry and Biological Activities (5 papers). Rixin Liang is often cited by papers focused on Traditional Chinese Medicine Analysis (19 papers), Neurological Disease Mechanisms and Treatments (7 papers) and Phytochemistry and Biological Activities (5 papers). Rixin Liang collaborates with scholars based in China, United States and United Kingdom. Rixin Liang's co-authors include Bin Yang, Hongjun Yang, Haiyu Xu, Lan Wang, Jianyong Zhang, Ren-Yi Yan, Shihuan Tang, Defeng Li, Shuangrong Gao and Bin Huang and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Rixin Liang

47 papers receiving 788 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rixin Liang China 18 387 272 203 135 97 48 795
Li‐Yuan Kang China 14 371 1.0× 331 1.2× 136 0.7× 110 0.8× 110 1.1× 35 792
Chengrong Xiao China 22 529 1.4× 226 0.8× 334 1.6× 102 0.8× 91 0.9× 69 1.1k
Zunpeng Shu China 17 362 0.9× 222 0.8× 149 0.7× 225 1.7× 97 1.0× 45 882
Junfei Gu China 19 496 1.3× 265 1.0× 209 1.0× 134 1.0× 124 1.3× 37 1.1k
Reza Mohebbati Iran 18 230 0.6× 221 0.8× 163 0.8× 172 1.3× 78 0.8× 79 892
Yingxue Fu China 18 590 1.5× 185 0.7× 229 1.1× 82 0.6× 156 1.6× 48 1.1k
Nou‐Ying Tang Taiwan 17 364 0.9× 226 0.8× 120 0.6× 167 1.2× 167 1.7× 19 873
Hong-Ling Tan China 22 570 1.5× 248 0.9× 350 1.7× 86 0.6× 109 1.1× 63 1.2k
Jung Joo Yoon South Korea 20 566 1.5× 140 0.5× 192 0.9× 130 1.0× 118 1.2× 67 1.1k
Jichun Han China 21 491 1.3× 154 0.6× 201 1.0× 104 0.8× 104 1.1× 41 1.0k

Countries citing papers authored by Rixin Liang

Since Specialization
Citations

This map shows the geographic impact of Rixin Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rixin Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rixin Liang more than expected).

Fields of papers citing papers by Rixin Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rixin Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rixin Liang. The network helps show where Rixin Liang may publish in the future.

Co-authorship network of co-authors of Rixin Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Rixin Liang. A scholar is included among the top collaborators of Rixin Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rixin Liang. Rixin Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Jing, Taotao Liu, Lan Wang, et al.. (2025). Rhubarb with Different Cooking Methods Restored the Gut Microbiota Dysbiosis and SCFAs in Ischemic Stroke Mice. Molecular Neurobiology. 62(8). 10228–10244. 1 indexed citations
2.
Chen, Ying, Qian Zhang, Bing Han, et al.. (2019). Anti-thrombosis Effects and Mechanisms by Xueshuantong Capsule Under Different Flow Conditions. Frontiers in Pharmacology. 10. 35–35. 19 indexed citations
3.
Chen, Tong, Ke Li, Haiyu Xu, et al.. (2019). Screening active ingredients of rosemary based on spectrum-effect relationships between UPLC fingerprint and vasorelaxant activity using three chemometrics. Journal of Chromatography B. 1134-1135. 121854–121854. 21 indexed citations
4.
Zhang, Jianyong, Rixin Liang, Lan Wang, & Bin Yang. (2018). Effects and mechanisms of Danshen-Shanzha herb-pair for atherosclerosis treatment using network pharmacology and experimental pharmacology. Journal of Ethnopharmacology. 229. 104–114. 75 indexed citations
5.
Zhang, Yanqiong, Qiuyan Guo, Qiu‐Yue Li, et al.. (2017). Main active constituent identification in Guanxinjing capsule, a traditional Chinese medicine, for the treatment of coronary heart disease complicated with depression. Acta Pharmacologica Sinica. 39(6). 975–987. 25 indexed citations
6.
Wang, Songsong, Haiyu Xu, Xuguang Wang, et al.. (2015). Characterization and rapid identification of chemical constituents of NaoXinTong capsules by UHPLC-linear ion trap/Orbitrap mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 111. 104–118. 60 indexed citations
7.
Cheng, Long, Guofeng Pan, Xiaodong Zhang, et al.. (2015). Yindanxinnaotong, a Chinese compound medicine, synergistically attenuatesatherosclerosis progress. Scientific Reports. 5(1). 12333–12333. 23 indexed citations
8.
Liu, Ting, Xin Mao, Rixin Liang, et al.. (2015). Fructus phyllanthi tannin fraction induces apoptosis and inhibits migration and invasion of human lung squamous carcinoma cells in vitro via MAPK/MMP pathways. Acta Pharmacologica Sinica. 36(6). 758–768. 31 indexed citations
9.
Wang, Jianlu, Lan Wang, Hongjun Yang, et al.. (2015). Prevention of atherosclerosis by Yindan Xinnaotong capsule combined with swimming in rats. BMC Complementary and Alternative Medicine. 15(1). 109–109. 16 indexed citations
10.
Zhang, Yanqiong, Songsong Wang, Weiliang Zhu, et al.. (2015). Deciphering the pharmacological mechanism of the Chinese formula Huanglian-Jie-Du decoction in the treatment of ischemic stroke using a systems biology-based strategy. Acta Pharmacologica Sinica. 36(6). 724–733. 19 indexed citations
11.
12.
Gao, Jian, Hongjun Yang, Jianxin Chen, et al.. (2013). Analysis of serum metabolites for the discovery of amino acid biomarkers and the effect of galangin on cerebral ischemia. Molecular BioSystems. 9(9). 2311–2321. 35 indexed citations
13.
Li, Tao, Yiwei Wang, Yanli Wang, et al.. (2013). [LC-MS quantification and pharmacokinetics of the multi-constituents of Huangqin Tang in rat plasma after different single oral doses].. PubMed. 48(6). 917–24. 7 indexed citations
14.
Zhang, Fangbo, Bin Huang, Ye Zhao, et al.. (2013). BNC Protects H9c2 Cardiomyoblasts from H2O2-Induced Oxidative Injury through ERK1/2 Signaling Pathway. Evidence-based Complementary and Alternative Medicine. 2013. 1–12. 45 indexed citations
15.
Zhang, Jianyong, Rixin Liang, Lan Wang, et al.. (2013). Effects of an aqueous extract of Crataegus pinnatifida Bge. var. major N.E.Br. fruit on experimental atherosclerosis in rats. Journal of Ethnopharmacology. 148(2). 563–569. 72 indexed citations
16.
17.
Yan, Ren-Yi, et al.. (2011). Bioactive polar compounds from stem bark of Magnolia officinalis. Fitoterapia. 83(2). 356–361. 51 indexed citations
18.
Wang, Lan, et al.. (2008). [Protection and its mechanism of catechin morphon on hypoxia-reoxygenation [corrected] induced injury in myocardial cells].. PubMed. 33(7). 801–5. 3 indexed citations
19.
Liang, Rixin. (2006). Protection of (-)-Catechin Gallate and (+)-Epicatechin on Xanthine-Xanthine Oxidase System Injury in Cultured Cardiomyocytes. Zhongguo shiyan fangjixue zazhi.
20.
Dunne, Mark J., E. A. Harding, Jonathan H. Jaggar, et al.. (1995). Potassium Channels, Imidazolines, and Insulin‐Secreting Cellsfn1. Annals of the New York Academy of Sciences. 763(1). 243–261. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li‐Yuan Kang Breakdown of academic impact, for papers by Chengrong Xiao Breakdown of academic impact, for papers by Zunpeng Shu Breakdown of academic impact, for papers by Junfei Gu Breakdown of academic impact, for papers by Reza Mohebbati Breakdown of academic impact, for papers by Yingxue Fu Breakdown of academic impact, for papers by Nou‐Ying Tang Breakdown of academic impact, for papers by Hong-Ling Tan Breakdown of academic impact, for papers by Jung Joo Yoon Breakdown of academic impact, for papers by Jichun Han
Rankless by CCL
2026